Drawing for WOMEN LEADERS IN ONCOLOGY

USPTO serial 87652642

WOMEN LEADERS IN ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 5450435Status 701Registered
Filing date
Status date
Registration date
Apr 17, 2018
Examiner
SPARER, KATERINA DOROTHY
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with WOMEN LEADERS IN ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Gryzlo

Matthew J. Gryzlo Barnes & Thornburg LLPOne North Wacker Drive, Suite 4400CHICAGO, IL 60606-2833United States

Goods and services

ClassDescriptionStatusFirst use
035Business and professional networking services, namely, creating research, business, and philanthropy connections in the field of oncology drug development, clinical research, and clinical practice; organization and implementation of professional networking opportunities in the nature of arranging and conducting professional business conferences and exhibitions and networking events in the fields of oncology drug development, clinical research, and clinical practice for business networking purposes; Business collaboration services, namely, promoting collaboration between current and rising women leaders in the field of oncology to achieve advances in the field of cancer research and treatmentACTIVEMar 15, 2015
036Charitable fundraising services, namely, providing financial and fundraising assistance for the purpose of charitable fundraisingACTIVEMar 15, 2015
041Creating and offering opportunities for mentoring of women in the field of oncology, namely, providing educational mentoring services and programs in the field of oncology; creating and providing opportunities for women in the field of oncology to learn about and be inspired by achievements in the field of oncology, namely, providing classes, seminars, and workshops in the field of oncology for womenACTIVEMar 15, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 8, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 8, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jan 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 15, 2024ES8RTEAS SECTION 8 RECEIVED—
Apr 17, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 17, 2018R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Mar 14, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 7, 2018ALIEASSIGNED TO LIE—
Feb 28, 2018CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Feb 27, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 5, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 5, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jan 29, 2018DOCKASSIGNED TO EXAMINER—
Oct 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance